Millet Products Study - Investigation of Glycemic Index and Satiety

Inclusion Criteria:

• Men, age 19-40, non-smoking
• Normal fasting plasma glucose (<5.6 mmol/L but not below 3.6 mmol/L)
• Normal glucose tolerance (evaluated by a 75 g oral glucose test, i.e. <7.8 mmol/L but not below 3.6 mmol/L)
• BMI ranging from 18.5 to 29.9 kg/m2

Exclusion Criteria:

• Insulin resistance (IR) will be calculated from fasting glucose and insulin values using the Homeostasis Assessment Model 2 (HOMA2). A HOMA2-IR value of greater than 1.0 will be considered indicative of insulin resistance (Levy J.C. et al. 1998).
• Regular consumption of millet as defined by questionnaire at screening defined as more than 1x per week
• Smoking or use of recreational drugs
• Heavy alcohol use (defined as typically >14 drinks per week or >4 drinks on one occasion)
• Very low fibre consumption as assessed by 24 hour food diary and self-reported fruit/vegetable/whole grain servings.
• Restrained eater as defined by the questionnaire at screening (Three Factor Eating Questionnaire, Stunkard et al.,1985)
• Food neophobic defined by Food Neophobia Scale questionnaire
• Unusual sleep patterns or irregular breakfast consumption
• Recent (i.e. >4 kg in previous 3 months) or intended weight loss or gain
• Food allergies or any life-threatening allergy (food or otherwise)
• Inflammatory bowel disease or other gastrointestinal disorders
• Use of drugs which influence carbohydrate metabolism
• Training or elite athletes
• Inability to adhere to Study Protocols